{"DataElement":{"publicId":"5154373","version":"1","preferredName":"HER2/ERBB2 Status Other Method Not IHC Or FISH Performed Text","preferredDefinition":"Text field to describe the specific method used to determine the patient's HER2/ERBB2 status, other than immunohistochemical (IHC) staining or Fluorescence In Situ Hybridization (FISH).","longName":"5154354v1.0:2181231v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"5154354","version":"1","preferredName":"HER2/Neu Status Other Method Negation Immunohistochemistry Staining Method Or Fluorescence In Situ Hybridization Performed","preferredDefinition":"The presence or absence of Her2/Neu on a tissue sample._Different than the one(s) previously specified or mentioned._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._An operation in which a term denies or inverts the meaning of another term or construction._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._Executed and carried through to completion.","longName":"5154351v1.0:5154352v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"5154351","version":"1","preferredName":"Her2/Neu Status","preferredDefinition":"The presence or absence of Her2/Neu on a tissue sample.","longName":"C16152","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HER2/Neu Status","conceptCode":"C16152","definition":"The presence or absence of Her2/Neu on a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DCC9D23-00FE-3243-E050-BB89AD43022A","latestVersionIndicator":"Yes","beginDate":"2016-03-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-11","modifiedBy":"ONEDATA","dateModified":"2016-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5154352","version":"1","preferredName":"Other Method Negation Immunohistochemistry Staining Method Or Fluorescence in Situ Hybridization Performed","preferredDefinition":"Different than the one(s) previously specified or mentioned.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.:An operation in which a term denies or inverts the meaning of another term or construction.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.:Executed and carried through to completion.","longName":"5154352v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DCC9D23-0114-3243-E050-BB89AD43022A","latestVersionIndicator":"Yes","beginDate":"2016-03-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-11","modifiedBy":"ONEDATA","dateModified":"2016-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DCC9D23-0125-3243-E050-BB89AD43022A","latestVersionIndicator":"Yes","beginDate":"2016-03-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for TCGA BRCA CDF form per request by K.Wildermuth. mc 3/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181231","version":"1","preferredName":"Descriptive Text","preferredDefinition":"The text that provides a description of a topic.","longName":"DESCR_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"ALPHANUMERIC","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3B72801-8C4C-3772-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2004-02-19","modifiedBy":"GDEEN","dateModified":"2022-05-31","changeDescription":"3/22/22 jk added \"Qualified\" RS as part of MCL quarterly content review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"If a method other than IHC OR","type":"Preferred Question Text","description":"If a method other than IHC OR FISH was used to determine HER2/ERBB2 Status, what method was used?","url":null,"context":"NCIP"}],"origin":"CTSP/CDDP: Clinical Trial Sequencing and Cancer Driver Discovery Projects","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DCCE006-3A2C-0E37-E050-BB89AD435604","latestVersionIndicator":"Yes","beginDate":"2016-03-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-03-11","modifiedBy":"COOPERM","dateModified":"2016-10-03","changeDescription":"Created for BRCA CDF per request by K.Wildermuth. mc 3/11/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}